# US 2017/0341975 A1 · Magnetizable glass ceramic composition and methods thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0341975 A1
- Document ID: US20170341975A1
- Status: Published application
- Kind: A1
- Application number: 15/603,150
- Filed: 2017-05-23
- Published: 2017-11-30
- Earliest claimed: 2016-05-27
- Assignees: Corning Incorporated
- Applicants: Corning Incorporated
- Inventors: Timothy Michael Gross; John Tyler Keech; Jeffrey Glenn Lynn; Jinlin Peng
- Web page: https://patentgrep.com/patent/US20170341975A1

## CPC

- C03C 10/0054: {containing PbO, SnO2, B2O3}
- A61K 47/02: Inorganic compounds
- C03C 10/0081: {having a magnetic crystal phase}
- C07K 1/14: Extraction; Separation; Purification
- C12N 15/1006: {by means of a solid support carrier, e.g. particles, polymers}
- G01N 33/5091: {for testing the pathological state of an organism}
- H01F 1/37: in a bonding agent
- C03C 2214/20: Glass-ceramics matrix
- C03C 2214/30: Methods of making the composites
- C03C: CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01F: MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES

## Abstract

A magnetizable glass ceramic composition including: a continuous first glass phase including SiO2, B2O3, P2O5, and R2O; a discontinuous second glass phase including at least one of SiO2, B2O3, P2O5, R2O, or mixtures thereof; and a discrete magnetizable crystalline phase dispersed in the discontinuous second glass phase, where R2O is selected from at least one of K2O, Li2O, Na2O, or mixtures thereof. Also disclosed are a method of making and a method of using the magnetizable glass ceramic composition.

## Claims

### Claim 1

A glass ceramic composition comprising:
a continuous first glass phase comprising SiO2, B2O3, P2O5, and R2O;
a discontinuous second glass phase comprising at least one of SiO2, B2O3, P2O5, R2O, or mixtures thereof; and
a discrete magnetizable crystalline phase dispersed in the discontinuous second phase,
where R2O is selected from at least one of K2O, Li2O, Na2O, or mixtures thereof.

### Claim 2 (depends on 1)

The glass ceramic composition of claim 1 wherein the continuous first phase is enriched in SiO2 relative to the discontinuous second glass phase, the discrete magnetizable phase, or both.

### Claim 3 (depends on 1)

The glass ceramic composition of claim 1 wherein the continuous first glass phase is enriched in Si relative to the discontinuous second glass phase.

### Claim 4 (depends on 1)

The glass ceramic composition of claim 1 wherein the discontinuous second glass phase is enriched in Fe and P relative to the continuous first glass phase.

### Claim 5 (depends on 1)

The glass ceramic composition of claim 1 wherein the discrete magnetizable crystalline phase comprises discrete magnetite crystals comprising a plurality of at least one of Fe2+ ions, Fe3+ ions, Fe2+ oxides, Fe3+ oxides, or mixtures thereof.

### Claim 6 (depends on 1)

The glass ceramic composition of claim 1 wherein R2O is K2O.

### Claim 7

A magnetizable glass ceramic composition, comprising:
60 to 70% SiO2,
1 to 2% Al2O3,
3 to 5% P2O5,
5 to 8% B2O3,
5 to 8% R2O where R2O is selected from at least one of K2O, Li2O, Na2O, or mixtures thereof, and
10 to 22% Fe2O3, based on a composition total of 100 mol %.

### Claim 8 (depends on 7)

The magnetizable glass ceramic composition of claim 7 wherein the composition has a Fe2+/total Fe mol ratio of 0.4 to 0.5.

### Claim 9 (depends on 7)

The magnetizable glass ceramic composition of claim 7 wherein the composition includes a plurality of iron ions in mixed oxidation states.

### Claim 10 (depends on 9)

The magnetizable glass ceramic composition of claim 9 wherein the plurality of iron ions in mixed oxidation states comprises magnetite crystals having a size of from 0.01 to 1 micrometer.

### Claim 11 (depends on 10)

The magnetizable glass ceramic composition of claim 10 wherein the magnetite crystals are magnetized by an external magnetic field, and the resulting magnetized magnetite crystals lose magnetization in the absence of the external magnetic field.

### Claim 12 (depends on 7)

The magnetizable glass ceramic composition of claim 7 wherein the composition has a melt temperature of from 1300 to 1600° C.

### Claim 13 (depends on 7)

A method of making the magnetizable glass ceramic composition of claim 7, comprising:
melting a mixture of a source of:
60 to 70% SiO2,
1 to 2% Al2O3,
3 to 5% P2O5,
5 to 8% B2O3,
5 to 8% R2O where R2O is selected from at least one of K2O, Li2O, Na2O, and mixtures thereof,
10 to 22% Fe2O3, based on a composition total of 100 mol %, and
reducing the size of the resulting solidified melt into a particulate powder.

### Claim 14 (depends on 13)

The method of making of claim 13, further comprising heat treating the melt mixture at from 500 to 800° C., for 1 to 24 hrs.

### Claim 15 (depends on 13)

The method of making of claim 13, wherein the particulate powder has a particle size of from 1 to 100 microns.

### Claim 16 (depends on 13)

The method of making of claim 13, wherein the particulate powder has a particle shape selected from at least one of: a sphere having a smooth surface; a sphere having a rough surface; an irregular or random shape; a shape having an aspect ratio of 1:1 to 1:5; or a mixture thereof.

### Claim 17 (depends on 13)

The method of making of claim 13, wherein the melting is accomplished at from 1300 to 1700° C., for 1 to 10 hrs.

### Claim 18 (depends on 13)

The method of making of claim 13, wherein the mixture has a mol ratio of Fe2+ to total Fe of from 0.4 to 0.5.

### Claim 19 (depends on 1)

An article comprising the glass ceramic composition of claim 1.

### Claim 20 (depends on 19)

The article of claim 19 wherein the article is used in at least one of nucleic acid purification, immuno-precipitation, exosome analysis, cell isolation, cell activation and expansion, nucleic acid isolation, rapid mRNA isolation, protein isolation, peptide purification, streptavidin-coupled magnetic beads, in vitro diagnostics assay development, magnetizable ink, and combinations thereof.
